IDELE, French Livestock Institute, UMT Cattle Herd Health Management, CS 40706, F-44307 Nantes, France; LUNAM Université, Oniris, Nantes-Atlantic College of Veterinary Medicine and Food sciences and Engineering, UMR BioEpAR, CS 40706, F-44307 Nantes, France; INRA, UMR1300 Biology, Epidemiology and Risk Analysis in animal health, CS 40706, F-44307 Nantes, France.
LUNAM Université, Oniris, Nantes-Atlantic College of Veterinary Medicine and Food sciences and Engineering, UMR BioEpAR, CS 40706, F-44307 Nantes, France; INRA, UMR1300 Biology, Epidemiology and Risk Analysis in animal health, CS 40706, F-44307 Nantes, France.
Vet Parasitol. 2014 Mar 17;201(1-2):95-109. doi: 10.1016/j.vetpar.2013.12.031. Epub 2014 Jan 9.
To investigate future tools for targeted selective treatment against gastrointestinal nematodes (GIN) in adult dairy cows, we evaluated herd and individual cow factors associated with the post-treatment milk production (MP) response over time. A field trial involving 20 pasturing dairy herds in Western France was conducted in autumn 2010 and autumn 2011. In each herd, lactating cows were randomly allocated to a treatment group (fenbendazole) (623 cows), or a control group (631 cows). Daily cow MP was recorded from 2 weeks before until 10 to 14 weeks after treatment. Individual serum anti-Ostertagia antibody levels (expressed as ODR), pepsinogen levels, faecal egg count (FEC), and bulk tank milk ODR were measured at the time of treatment. Moreover, in each herd, information regarding heifers' grazing and treatment history was collected to assess the Time of Effective Contact (TEC, expressed in months) with GIN infective larvae before the first calving. TEC was expected to reflect the development of immunity against GIN, and TEC=8 months was a cautious threshold over which the resistance to re-infection was expected to be established. Daily MP averaged by week was analyzed using linear mixed models with three nested random effects (cow within herd and herd within year). The overall treatment effect was significant but slight (maximum=+0.85 kg/d on week 6 after treatment), and the evolution of treated cows' MP differed significantly according to several factors. At the herd level, cows from low-TEC herds responded better than cows from high-TEC (≥ 8 months) herds; cows from herds in which the percentage of positive FEC was >22.6% (median value) responded better than those from herds where it was lower. At the individual cow level, primiparous cows, cows with days in milk (DIM) < or = 100 at the time of treatment, and cows with low individual ODR (< or = 0.38) responded better than multiparous cows, cows with DIM>100, and cows with higher ODR, respectively. These results highlight the variability of the treatment response, suggesting that whole herd anthelmintic treatment are not always appropriate, and propose promising key criteria for targeted selective treatment for GIN in dairy cows. Particularly, the TEC is an original criterion which lends support for a simultaneous on-farm qualitative analysis of grazing management factors.
为了研究针对成年奶牛胃肠道线虫(GIN)的靶向选择性治疗的未来工具,我们评估了与随时间推移的治疗后产奶量(MP)反应相关的畜群和个体牛因素。2010 年秋季和 2011 年秋季在法国西部的 20 个放牧奶牛场进行了一项现场试验。在每个畜群中,泌乳奶牛被随机分配到治疗组(芬苯达唑)(623 头)或对照组(631 头)。从治疗前 2 周到治疗后 10-14 周,每天记录奶牛的产奶量。在治疗时测量个体血清抗奥斯特拉西亚抗体水平(表示为 ODR)、胃蛋白酶原水平、粪便卵计数(FEC)和牛群奶 ODR。此外,在每个畜群中,收集了关于小母牛放牧和治疗史的信息,以评估第一次产犊前与 GIN 感染性幼虫的有效接触时间(TEC,以月表示)。TEC 预计反映对 GIN 的免疫力发展,TEC=8 个月是一个谨慎的阈值,超过该阈值预计会建立对再感染的抵抗力。使用具有三个嵌套随机效应(畜群内和畜群内的牛和畜群内的年)的线性混合模型分析每周的平均每日 MP。整体治疗效果显著但轻微(治疗后第 6 周最高为+0.85kg/d),并且治疗奶牛的 MP 演变根据几个因素而显著不同。在畜群水平上,来自低 TEC 畜群的奶牛比来自高 TEC(≥8 个月)畜群的奶牛反应更好;来自 FEC 阳性百分比>22.6%(中位数)的畜群的奶牛比来自百分比较低的畜群的奶牛反应更好。在个体牛水平上,初产牛、治疗时产奶天数(DIM)≤100 的奶牛和个体 ODR 较低(≤0.38)的奶牛比经产牛、DIM>100 的奶牛和 ODR 较高的奶牛反应更好。这些结果强调了治疗反应的可变性,表明整个畜群驱虫治疗并不总是合适的,并为奶牛胃肠道线虫的靶向选择性治疗提出了有希望的关键标准。特别是,TEC 是一个原始标准,为同时进行放牧管理因素的定性农场分析提供了支持。